
Allan Gibofsky, MD, JD
Advertisement
Articles by Allan Gibofsky, MD, JD
Advertisement
Latest Updated Articles
Biosimilars for Immune-Mediated Inflammatory Diseases – A Managed Care PerspectivePublished: November 1st 2022 | Updated:
Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current EvidencePublished: November 1st 2022 | Updated:
Provider and Patient Knowledge Gaps on Biosimilars: Insights From SurveysPublished: November 1st 2022 | Updated:
Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid ArthritisPublished: December 24th 2012 | Updated:
Comparative Effectiveness of Current Treatments for Rheumatoid ArthritisPublished: December 24th 2012 | Updated:
Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis: A SynopsisPublished: May 31st 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention
5



